Explore the journal
Psyllium is one of the rare supplements with a boring mechanism and a useful evidence base. It forms a gel, changes stool texture, and can modestly lower LDL…
Read the articleProbiotic supplements may help in specific situations, but strain, dose, storage, and health context matter more than the CFU number on the label.
Read the articleN-acetylcysteine has real clinical uses, yet the wellness case for daily capsules rests on thin evidence and a supplement supply chain that is hard to trust.
Read the articleBerberine may modestly improve blood sugar and lipids, but the evidence is short-term, mixed, and complicated by real drug-interaction risks.
Read the articleAshwagandha has some stress and sleep evidence, but liver, thyroid, pregnancy, medication, and product-quality cautions should shape any discussion.
Read the articleCollagen peptides may modestly help joint pain, but product type, study quality, allergy risk, supplement safety, and realistic expectations matter.
Read the articlePsyllium has evidence for constipation and modest LDL shifts, but it needs enough fluid, medication caution, and realistic expectations about benefits.
Read the articleCollagen supplements may modestly affect skin hydration and elasticity, but the evidence is product-specific, industry-influenced, and far from the anti-ageing claims marketed online.
Read the articleCoQ10 has plausible biology and limited clinical signals, but evidence for statin muscle pain is mixed and medication interactions deserve caution.
Read the articleVitamin D matters for bone and deficiency, but routine high-dose supplements are not a proven longevity strategy and can cause harm in excess.
Read the articleFind a little clarity
